Novo Nordisk

Contact
novonordisk.at
+43-1-4051501

Novo Nordisk Pharma GmbH

Opernring 3
1010 Wien
Austria
+43-1-4051501
novonordisk.at
Contact
Profile News
Contact

About Novo Nordisk

Novo Nordisk is a global pharmaceutical company with more than 90 years of innovation and leadership in the treatment of diabetes. This heritage has given us experiences and abilities that enable us to help people fight other severe chronic diseases such as blood clotting disorders, growth disorders, and obesity.

Read more about Novo Nordisk
Facts about Novo Nordisk
  • Focus : Manufacturer
  • Industry : Pharma

News about Novo Nordisk

Novo Nordisk

30-Apr-2024 | science

Breakthrough in research on brown fat

Hope for strategies that support weight loss: Researchers from Denmark and Germany have found brown fat’s “off-switch"

Read news
Novo Nordisk

26-Mar-2024 | business & finance

Possible billion-euro deal: Novo Nordisk wants to acquire MHH spin-off

Cardior Pharmaceuticals is developing a drug for the treatment of heart failure. The Danish pharmaceutical group Novo Nordisk is planning to acquire the ...

Read news
Novo Nordisk

19-Aug-2020 | research and development

Evotec and Novo Nordisk form alliance to develop novel therapies for kidney diseases

Milestone potential of more than € 150 m per product

Read news
Novo Nordisk

23-Aug-2018 | business & finance

Evotec and Novo Nordisk form research alliance in diabetes and obesity

Evotec AG announced a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat patients suffering from diabetes ...

Read news
Novo Nordisk

20-Aug-2018 | business & finance

Novo Nordisk acquires Bristol based biopharmaceutical start-up

Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at ...

Read news
Novo Nordisk

13-Oct-2010 | business & finance

Novo Nordisk completes divestment of ZymoGenetics, Inc.

Bristol-Myers Squibb Company and ZymoGenetics, Inc. have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers ...

Read news
Novo Nordisk

10-Sep-2010 | business & finance

Novo Nordisk divests its ownership of ZymoGenetics, Inc.

Bristol-Myers Squibb Company and ZymoGenetics, Inc. have announced the signing of a definitive agreement providing for the acquisition of ZymoGenetics by ...

Read news
Novo Nordisk

13-Jan-2010 | manufacturing

Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil

Expansion of Cooperation With Diabetes Leader Novo Nordisk

Read news
Show more news about Novo Nordisk

Here you will find Novo Nordisk Pharma GmbH